抗抑郁药与安慰剂相比,用于过度饮食障碍患者:系统性审查和元分析
Angeliki L Sioziou1, Andreas S Lappas2, Menelaos Skarlatos1
1Laboratory of Hygiene, Social & Preventive Medicine and Medical Statistics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.
概括
与安慰剂相比,抗抑郁药在治疗暴饮暴食障碍 (BED) 中表现出有效性,改善缓解率并减少暴饮暴食的频率. 然而,小样本大小限制了概括性,需要进一步研究长期影响和其他药物治疗方法.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 暴饮暴食 (BED) 是最常见的饮食障碍.
- 心理治疗是第一线建议的,但面临着挑战.
- 抗抑郁药可以获得,但缺乏强有力的证据来治疗BED.
研究的目的:
- 系统地审查抗抑郁药对BED的疗效和安全性.
- 分析随机对照试验 (RCT),将抗抑郁药与安慰剂进行比较.
- 评估缓解和暴饮暴食频率的主要结果.
主要方法:
- 在五个数据库中搜索到到2023年11月23日的RCT.
- 对16个RCT (984名参与者) 进行了双对元分析.
- 评估了初级 (缓解,狂欢频率) 和二级结局 (反应,精神病理学,抑郁,焦虑,BMI,不良事件).
主要成果:
- 与安慰剂相比,抗抑郁药显著改善了缓解率 (RR: 1.39) 和减少过度饮食频率 (SMD: -0.29).
- 抗抑郁药也在治疗反应和抑郁症症状减少方面表现出优越性.
- 在其他二次结果中没有发现显著差异,对不良事件的数据有限.
结论:
- 抗抑郁药似乎有效地减少BED症状,特别是缓解和暴饮暴食的频率.
- 小样本大小和效果大小限制了研究结果的概括性和临床实用性.
- 需要更多的大规模随访期较长的RCT来确认BED药物治疗的疗效和安全性.
相关概念视频
01:23Binge Eating Disorders
63
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
63
01:30Bulimia Nervosa
65
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
65
01:23Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
01:54The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
380
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
380
01:28Anorexia Nervosa
62
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
62